NPI: 1770758526 · PHOENIX, AZ 85035 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/23/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/23/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 43,396 | $1.35M |
| 2019 | 42,593 | $1.38M |
| 2020 | 40,736 | $1.51M |
| 2021 | 30,521 | $1.38M |
| 2022 | 28,475 | $1.21M |
| 2023 | 18,435 | $1.20M |
| 2024 | 11,479 | $1.01M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 83,420 | 6,578 | $8.75M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 774 | 447 | $291K |
| A4657 | Syringe, with or without needle, each | 24,906 | 3,580 | $1K |
| J1756 | Injection, iron sucrose, 1 mg | 13,276 | 3,255 | $1K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 40,973 | 3,362 | $567.48 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 458 | 380 | $0.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 33,962 | 2,737 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 18 | 17 | $0.00 |
| 82728 | 583 | 477 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,052 | 115 | $0.00 |
| 83550 | 556 | 456 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 324 | 298 | $0.00 |
| 90674 | 221 | 200 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 155 | 78 | $0.00 |
| 90677 | 12 | 12 | $0.00 | |
| 85041 | 1,320 | 1,091 | $0.00 | |
| 85048 | 1,309 | 1,088 | $0.00 | |
| 83970 | 877 | 714 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 10,398 | 744 | $0.00 |
| 83540 | 560 | 457 | $0.00 | |
| 90661 | 29 | 27 | $0.00 | |
| 82108 | 107 | 91 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 255 | 97 | $0.00 |
| 90662 | 73 | 69 | $0.00 | |
| 90670 | 17 | 16 | $0.00 |